Inspire Investing’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $449K | Buy |
84,520
+40,793
| +93% | +$217K | 0.05% | 319 |
|
|
2025
Q1 | $388K | Buy |
43,727
+12,354
| +39% | +$110K | 0.05% | 322 |
|
|
2024
Q4 | $430K | Buy |
31,373
+14,406
| +85% | +$198K | 0.05% | 348 |
|
|
2024
Q3 | $465K | Buy |
16,967
+2,538
| +18% | +$69.5K | 0.05% | 314 |
|
|
2024
Q2 | $353K | Sell |
14,429
-2,226
| -13% | -$54.4K | 0.04% | 493 |
|
|
2024
Q1 | $355K | Sell |
16,655
-3,559
| -18% | -$75.9K | 0.04% | 759 |
|
|
2023
Q4 | $387K | Buy |
20,214
+1,212
| +6% | +$23.2K | 0.04% | 440 |
|
|
2023
Q3 | $305K | Buy |
19,002
+5,505
| +41% | +$88.3K | 0.04% | 754 |
|
|
2023
Q2 | $313K | Buy |
13,497
+1,711
| +15% | +$39.7K | 0.04% | 695 |
|
|
2023
Q1 | $274K | Sell |
11,786
-4,992
| -30% | -$116K | 0.03% | 519 |
|
|
2022
Q4 | $243K | Buy |
16,778
+6,149
| +58% | +$89.2K | 0.03% | 350 |
|
|
2022
Q3 | $203K | Sell |
10,629
-990
| -9% | -$18.9K | 0.03% | 742 |
|
|
2022
Q2 | $211K | Buy |
11,619
+2,241
| +24% | +$40.7K | 0.03% | 675 |
|
|
2022
Q1 | $236K | Buy |
9,378
+503
| +6% | +$12.7K | 0.03% | 513 |
|
|
2021
Q4 | $245K | Buy |
8,875
+1,879
| +27% | +$51.9K | 0.03% | 731 |
|
|
2021
Q3 | $226K | Sell |
6,996
-1,188
| -15% | -$38.4K | 0.03% | 683 |
|
|
2021
Q2 | $250K | Buy |
8,184
+248
| +3% | +$7.58K | 0.03% | 564 |
|
|
2021
Q1 | $242K | Sell |
7,936
-4,092
| -34% | -$125K | 0.04% | 563 |
|
|
2020
Q4 | $238K | Sell |
12,028
-608
| -5% | -$12K | 0.05% | 553 |
|
|
2020
Q3 | $165K | Buy |
+12,636
| New | +$165K | 0.05% | 396 |
|
|
2018
Q1 | – | Sell |
-1,617
| Closed | -$56K | – | 513 |
|
|
2017
Q4 | $56K | Buy |
+1,617
| New | +$56K | 0.05% | 558 |
|